Tatva Chintan Pharma Chem Limited (NSE:TATVA)

Tatva Chintan Pharma Chem Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	152.05	57.64	113.74	353.04	273.65	630.17
Short-Term Investments	-	3.4	3.27	3.13	138.5	8.02
Trading Asset Securities	-	-	-	100.51	-	-
Cash & Short-Term Investments	152.05	61.04	117.01	456.68	412.15	638.19
Cash Growth	-11.46%	-47.83%	-74.38%	10.80%	-35.42%	1098.70%
Accounts Receivable	1,784	1,190	895.49	720.24	875.03	584.27
Other Receivables	1.44	22.76	11.9	5.18	3.21	27.21
Receivables	1,788	1,216	909.76	727.83	879.96	613.09
Inventory	2,489	1,961	1,340	1,528	1,625	1,700
Prepaid Expenses	-	56.94	49.29	55.84	37.1	21.22
Other Current Assets	259.42	200.68	236.85	211.05	168.31	1,384
Total Current Assets	4,688	3,495	2,652	2,979	3,123	4,356
Property, Plant & Equipment	6,316	6,275	5,471	4,995	4,265	2,108
Long-Term Investments	40	40	-	-	-	-
Other Intangible Assets	65.46	17.69	29.75	39.61	4.76	3.17
Long-Term Deferred Tax Assets	19.21	95.67	126.24	122.97	164.03	87.1
Long-Term Deferred Charges	-	50.57	29.24	-	-	-
Other Long-Term Assets	58.12	62.94	53.94	50.92	32.13	26.02
Total Assets	11,187	10,037	8,362	8,187	7,589	6,581

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	855.24	582.46	326.89	450.31	321.88	445.13
Accrued Expenses	6.39	148.23	123.4	87.97	67.46	75.75
Short-Term Debt	1,655	1,143	357.49	100	1,562	924.69
Current Portion of Long-Term Debt	-	10.3	6.39	36.32	98.18	143.58
Current Income Taxes Payable	21.27	3.17	20.16	0.76	2.13	10.23
Current Unearned Revenue	-	92.04	70.21	21.72	33.12	18.38
Other Current Liabilities	417.08	151.82	55.73	99.55	302.05	94.2
Total Current Liabilities	2,955	2,131	960.27	796.63	2,387	1,712
Long-Term Debt	44.65	50.1	-	6.39	42.3	131.11
Long-Term Unearned Revenue	11.06	12.01	-	-	-	0.08
Pension & Post-Retirement Benefits	-	10.36	-	-	-	-
Other Long-Term Liabilities	29.8	15.53	13.98	13.34	11.45	6.51
Total Liabilities	3,041	2,219	974.25	816.36	2,441	1,850

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	233.92	233.92	233.92	233.92	221.65	221.65
Additional Paid-In Capital	-	4,044	4,044	4,044	2,090	2,090
Retained Earnings	-	3,484	3,085	3,077	2,825	2,415
Comprehensive Income & Other	7,913	55.54	25.08	15.84	10.75	4.27
Shareholders' Equity	8,147	7,818	7,388	7,371	5,148	4,731
Total Liabilities & Equity	11,187	10,037	8,362	8,187	7,589	6,581

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,700	1,204	363.88	142.71	1,703	1,199
Net Cash (Debt)	-1,548	-1,143	-246.87	313.97	-1,290	-561.19
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-66.18	-48.85	-10.55	13.72	-58.22	-26.10
Filing Date Shares Outstanding	23.39	23.39	23.39	23.39	22.17	22.17
Total Common Shares Outstanding	23.39	23.39	23.39	23.39	22.17	22.17
Working Capital	1,733	1,364	1,692	2,182	735.59	2,644
Book Value Per Share	348.25	334.20	315.84	315.10	232.25	213.44
Tangible Book Value	8,081	7,800	7,358	7,331	5,143	4,728
Tangible Book Value Per Share	345.45	333.44	314.57	313.41	232.04	213.30
Buildings	-	2,018	1,698	1,544	504.8	376.53
Machinery	-	4,908	4,107	3,005	1,478	1,153
Construction In Progress	-	233.48	215.35	729.27	2,307	514.91

Data Source: S&P Global Market Intelligence Last updated: Oct 19, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error